These results, taken together, indicate that STAG2 inactivation may impair the ability of BRAF-mutant thyroid cancer cells to utilize glutamine and decrease the antioxidant capacity and ROS clearance of cells under glutamine stress condition. This evidence concerns the gene BRAF and thyroid gland carcinoma.